For citations:
Patrikeeva IM, Lushpaeva YA, Knaub NV, Ustinova EA, Belikov OA, Dolgikh MB, Malysheva TY. Experience of using the interleukin-6 inhibitor olokizumab in patients with rheumatoid arthritis in real-life clinical practice (based on data from Tyumen Regional Rheumatology Center). Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2025;19(1):57-63. (In Russ.) https://doi.org/10.14412/1996-7012-2025-1-57-63
Email this article 